COVID-19: Toxicities of Potential Therapies

May 13, 2020 • 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

July 09, 2024 • 00:26:28
Episode Cover

Should We Use NIPPV for Preoxygenation for All Intubations?

Over 1 million critically ill patients are intubated each year in the US.  Hypoxemia occurs in up to 20% of patients and can lead...

Listen

Episode 0

January 06, 2020 • 00:34:59
Episode Cover

A Year in Review: Key Articles from the 2019 Critical Care Literature

A plethora of literature was published during the course of 2019.  In this podcast, we review several key articles published in the 2019 critical...

Listen

Episode 0

February 28, 2023 • 00:27:55
Episode Cover

ECPR for OHCA? - The INCEPTION Trial

In recent years, several single center trials have demonstrated positive outcomes in patients with OHCA randomized to receive ECPR compared with patients who received...

Listen